Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

drug resistance

  • You have access
    Lung Cancer Cell Line Sensitivity to Zoledronic Acid Is BAX-dependent
    TAKAYUKI AOYAGI, TAKESHI MORII, KOUKI OHTSUKA, HIROAKI OHNISHI, TAKASHI TAJIMA, AKIRA YOSHIYAMA, KAZUO MOCHIZUKI, KAZUHIKO SATOMI and SHOICHI ICHIMURA
    Anticancer Research December 2013, 33 (12) 5357-5363;
  • You have access
    Human Pancreatic Cancer Cells with Acquired Gemcitabine Resistance Exhibit Significant Up-regulation of Peroxiredoxin-2 Compared to Sensitive Parental Cells
    SHIGEYUKI SUENAGA, YASUHIRO KURAMITSU, YUFENG WANG, BYRON BARON, TAKAO KITAGAWA, JUNKO AKADA, KAZUHIRO TOKUDA, SEIJI KAINO, SHIN-ICHIRO MAEHARA, YOSHIHIKO MAEHARA, ISAO SAKAIDA and KAZUYUKI NAKAMURA
    Anticancer Research November 2013, 33 (11) 4821-4826;
  • You have access
    Prevention of Carboplatin-induced Resistance in Human Ovarian Tumor Xenografts by Selenite
    PAULA B. CAFFREY and GERALD D. FRENKEL
    Anticancer Research October 2013, 33 (10) 4249-4254;
  • You have access
    Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
    XIANG-SHU XIAN, HYEYEON PARK, MYUNG-GYU CHOI and JAE MYUNG PARK
    Anticancer Research June 2013, 33 (6) 2541-2547;
  • You have access
    Comparison of Prognostic Value of In Vitro Drug Resistance and Bone Marrow Residual Disease on Day 15 of Therapy in Childhood Acute Lymphoblastic Leukemia
    JAN STYCZYNSKI, MAGDALENA PIATKOWSKA, ANNA JAWORSKA-POSADZY, KRZYSZTOF CZYZEWSKI, MALGORZATA KUBICKA, BEATA KOLODZIEJ, BEATA KURYLO-RAFINSKA, ROBERT DEBSKI, MONIKA POGORZALA and MARIUSZ WYSOCKI
    Anticancer Research December 2012, 32 (12) 5495-5499;
  • You have access
    Studies on the Activity of Two Trans-Planaramine Platinum(II) Complexes Coded as DH4 and DH5 in Human Ovarian Tumour Models
    NARJES DEQNAH, JUN Q. YU, PHILIP BEALE and FAZLUL HUQ
    Anticancer Research December 2012, 32 (12) 5331-5336;
  • You have access
    Curcumin Resistance Induced by Hypoxia in HepG2 Cells Is Mediated by Multidrug-resistance-associated Proteins
    TITIPATIMA SAKULTERDKIAT, CHANTRAGAN SRISOMSAP, RACHANEE UDOMSANGPETCH, JISNUSON SVASTI and KRIENGSAK LIRDPRAPAMONGKOL
    Anticancer Research December 2012, 32 (12) 5337-5342;
  • You have access
    Studies on Combination of Platinum Drugs Cisplatin and Oxaliplatin with Phytochemicals Anethole and Curcumin in Ovarian Tumour Models
    MEHER U. NESSA, PHILIP BEALE, CHARLES CHAN, JUN Q. YU and FAZLUL HUQ
    Anticancer Research November 2012, 32 (11) 4843-4850;
  • You have access
    Epigallocatechin Gallate Acts Synergistically in Combination with Cisplatin and Designed trans-palladiums in Ovarian Cancer Cells
    MOHAMMED EHSANUL HOQUE MAZUMDER, PHILIP BEALE, CHARLES CHAN, JUN Q. YU and FAZLUL HUQ
    Anticancer Research November 2012, 32 (11) 4851-4860;
  • You have access
    Decitabine, a DNA Methyltransferase Inhibitor, Reduces P-Glycoprotein mRNA and Protein Expressions and Increases Drug Sensitivity in Drug-resistant MOLT4 and Jurkat Cell Lines
    KENJI ONDA, RIEKO SUZUKI, SACHIKO TANAKA, HIROKAZU OGA, KITARO OKA and TOSHIHIKO HIRANO
    Anticancer Research October 2012, 32 (10) 4439-4444;

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire